Literature DB >> 21516317

Molecular dynamics and docking simulations as a proof of high flexibility in E. coli FabH and its relevance for accurate inhibitor modeling.

Yunierkis Pérez-Castillo1, Matheus Froeyen, Miguel Angel Cabrera-Pérez, Ann Nowé.   

Abstract

Bacterial β-ketoacyl-acyl carrier protein synthase III (FabH) has become an attractive target for the development of new antibacterial agents which can overcome the increased resistance of these pathogens to antibiotics in clinical use. Despite several efforts have been dedicated to find inhibitors for this enzyme, it is not a straightforward task, mainly due its high flexibility which makes difficult the structure-based design of FabH inhibitors. Here, we present for the first time a Molecular Dynamics (MD) study of the E. colil FabH enzyme to explore its conformational space. We compare the flexibility of this enzyme for the unliganded protein and an enzyme-inhibitor complex and find a correspondence between our modeling results and the experimental evidence previously reported for this enzyme. Furthermore, through a 100 ns MD simulation of the unliganded enzyme we extract useful information related to the concerted motions that take place along the principal components of displacement. We also establish a relation between the presence of water molecules in the oxyanion hole with the conformational stability of structural important loops. Representative conformations of the binding pocket along the whole trajectory of the unliganded protein are selected through cluster analysis and we find that they contain a conformational diversity which is not provided by the X-ray structures of ecFabH. As a proof of this last hypothesis, we use a set of 10 FabH inhibitors and show that they cannot be correctly modeled in any available X-ray structure, while by using our set of conformations extracted from the MD simulations, this task can be accomplish. Finally, we show the ability of short MD simulations for the refinement of the docking binding poses and for MM-PBSA calculations to predict stable protein-inhibitor complexes in this enzyme.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21516317     DOI: 10.1007/s10822-011-9427-z

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  66 in total

1.  Implicit solvation based on generalized Born theory in different dielectric environments.

Authors:  Michael Feig; Wonpil Im; Charles L Brooks
Journal:  J Chem Phys       Date:  2004-01-08       Impact factor: 3.488

Review 2.  The need for new antibiotics.

Authors:  D M Livermore
Journal:  Clin Microbiol Infect       Date:  2004-11       Impact factor: 8.067

3.  Interactive essential dynamics.

Authors:  John Mongan
Journal:  J Comput Aided Mol Des       Date:  2004-06       Impact factor: 3.686

Review 4.  Use of genomics to select antibacterial targets.

Authors:  Michael J Pucci
Journal:  Biochem Pharmacol       Date:  2006-01-18       Impact factor: 5.858

5.  Can principal components yield a dimension reduced description of protein dynamics on long time scales?

Authors:  Oliver F Lange; Helmut Grubmüller
Journal:  J Phys Chem B       Date:  2006-11-16       Impact factor: 2.991

6.  Separate entrance and exit portals for ligand traffic in Mycobacterium tuberculosis FabH.

Authors:  Sarbjot Sachdeva; Faik N Musayev; Mamoun M Alhamadsheh; J Neel Scarsdale; H Tonie Wright; Kevin A Reynolds
Journal:  Chem Biol       Date:  2008-04

7.  The 1.8 A crystal structure and active-site architecture of beta-ketoacyl-acyl carrier protein synthase III (FabH) from escherichia coli.

Authors:  C Davies; R J Heath; S W White; C O Rock
Journal:  Structure       Date:  2000-02-15       Impact factor: 5.006

8.  Purification, characterization, and identification of novel inhibitors of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.

Authors:  Xin He; Kevin A Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

9.  Combining specificity determining and conserved residues improves functional site prediction.

Authors:  Olga V Kalinina; Mikhail S Gelfand; Robert B Russell
Journal:  BMC Bioinformatics       Date:  2009-06-09       Impact factor: 3.169

10.  Human fatty acid synthase: properties and molecular cloning.

Authors:  A Jayakumar; M H Tai; W Y Huang; W al-Feel; M Hsu; L Abu-Elheiga; S S Chirala; S J Wakil
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

View more
  5 in total

1.  Toward the computer-aided discovery of FabH inhibitors. Do predictive QSAR models ensure high quality virtual screening performance?

Authors:  Yunierkis Pérez-Castillo; Maykel Cruz-Monteagudo; Cosmin Lazar; Jonatan Taminau; Mathy Froeyen; Miguel Angel Cabrera-Pérez; Ann Nowé
Journal:  Mol Divers       Date:  2014-03-27       Impact factor: 2.943

2.  Conformational diversity of bacterial FabH: implications for molecular recognition specificity.

Authors:  Anuradha Mittal; Michael E Johnson
Journal:  J Mol Graph Model       Date:  2014-11-15       Impact factor: 2.518

3.  Regulation of cell size in response to nutrient availability by fatty acid biosynthesis in Escherichia coli.

Authors:  Zhizhong Yao; Rebecca M Davis; Roy Kishony; Daniel Kahne; Natividad Ruiz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

4.  Cytotoxic and Antifungal Amides Derived from Ferulic Acid: Molecular Docking and Mechanism of Action.

Authors:  Mayara Castro de Morais; Yunierkis Perez-Castillo; Valdenizia Rodrigues Silva; Luciano de Souza Santos; Milena Botelho Pereira Soares; Daniel Pereira Bezerra; Ricardo Dias de Castro; Damião Pergentino de Sousa
Journal:  Biomed Res Int       Date:  2021-11-01       Impact factor: 3.411

5.  Molecular basis of HHQ biosynthesis: molecular dynamics simulations, enzyme kinetic and surface plasmon resonance studies.

Authors:  Anke Steinbach; Christine K Maurer; Elisabeth Weidel; Claudia Henn; Christian Brengel; Rolf W Hartmann; Matthias Negri
Journal:  BMC Biophys       Date:  2013-08-01       Impact factor: 4.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.